首页|期刊导航|中国中药杂志|基于上皮-间充质转化探讨盐炙杜仲治疗肾纤维化增效的机制研究

基于上皮-间充质转化探讨盐炙杜仲治疗肾纤维化增效的机制研究OA

Study on mechanism of salt-stir fried Eucommiae Cortex to enhance therapeutic efficacy on renal fibrosis through epithelial-mesenchymal transition

中文摘要英文摘要

该研究旨在系统比较杜仲(EC)和盐炙杜仲(SEC)对腺嘌呤诱导的大鼠肾纤维化改善作用的差异,并基于上皮-间充质转化(EMT)探讨 SEC 治疗肾纤维化增效的分子机制.将大鼠随机分为空白对照组,模型组,阳性药组,EC 及 SEC 低、中、高剂量组.采用蛋白免疫印迹和免疫荧光技术检测肾脏组织 α-平滑肌动蛋白(α-SMA)、Ⅰ型胶原(collagen Ⅰ)、纤连蛋白(fi-bronectin)、波形蛋白(vimentin)等纤维化标志蛋白的表达;通过实时荧光定量逆转录 PCR 检测肾组织中 EMT 关键转录因子Snail 同源物 1(Snai1)、扭转相关蛋白 1(Twist1)、锌指 E 盒结合同源框蛋白 1(ZEB1),以及炎症因子肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)的转录表达水平.在体外实验中,利用转化生长因子-β(TGF-β)刺激肾小管上皮 NRK-52E 细胞建立纤维化模型,评估 EC 和 SEC 对纤维化标志蛋白表达及 EMT 过程的抑制作用,并联合网络药理学与蛋白免疫印迹技术深入探讨其分子机制.EC 和 SEC 均能显著降低腺嘌呤诱导的肾纤维化大鼠及 TGF-β 刺激的 NRK-52E 细胞中纤维化标志指标 fibronectin、collagen Ⅰ、vimentin 和 α-SMA 的蛋白表达水平,并明显抑制 EMT 关键转录因子 Snai1、Twist1、ZEB1 以及炎症因子 TNF-α、IL-1β、IL-6的转录表达,且 SEC 抑制效果强于 EC.网络药理学分析提示,SEC 中显著变化的化学成分聚焦丝裂原活化蛋白激酶(MAPK)信号通路发挥作用;进一步实验证实,EC 和 SEC 可显著抑制腺嘌呤及 TGF-β介导的p38 丝裂原活化蛋白激酶(p38)磷酸化及其上游凋亡信号调节激酶1(ASK1)蛋白的高表达,且SEC 的抑制作用更为显著.此外,ASK1 抑制剂 Selonsertib 能够明显下调 TGF-β 刺激的 NRK-52E 细胞中 EMT 和 p38 磷酸化水平.因此,SEC 可通过阻止 EMT 进程,从而对肾纤维化的治疗产生增效作用,其具体机制与 ASK1/p38 信号通路的抑制相关.

This study aims to systematically compare the differences in the effects of Eucommiae Cortex(EC)and salt-stir fried Eucommiae Cortex(SEC)on improving adenine-induced renal fibrosis in rats and explore the molecular mechanism by which SEC enhances the therapeutic effect on renal fibrosis based on epithelial-mesenchymal transition(EMT).Rats were randomly divided into a blank control group,model group,positive drug group,and groups with low,medium,and high-dose EC and SEC.Western blot and immunofluorescence techniques were utilized to detect the expression of fibrosis marker proteins such as α-smooth actin(α-SMA),collagen Ⅰ,fibronectin,and vimentin in renal tissue.Real-time fluorescent quantitative reverse transcription polymerase chain reaction(PCR)was used to detect the transcriptional expression levels of key EMT transcription factors snail family transcriptional repressor 1(Snai1),twist family BHLH transcription factor 1(Twist1),zinc finger E-box binding homeobox 1(ZEB1),inflammatory factors tumor necrosis factor-α(TNF-α),interleukin-1β(IL-1β),and interleukin-6(IL-6)in renal tissue.In in vitro experiments,a fibrosis model was established by using transforming growth factor-β(TGF-β)to stimulate renal tubular epithelial NRK-52E cells,thereby evaluating the inhibitory effects of EC and SEC on the protein expression of fibrosis markers and the EMT process.The underlying molecular mechanism was further explored by combining network pharmacology and western blot.Both EC and SEC significantly reduced the protein expression levels of fibrosis markers including fibronectin,collagen Ⅰ,vimentin,and α-SMA and obviously inhibited the transcriptional expression of key EMT transcription factors including Snai1,Twist1,and ZEB1 and inflammatory factors including TNF-α,IL-1β,and IL-6 in rats with adenine-induced renal fibrosis and in NRK-52E cells stimulated by TGF-β.The inhibitory effects of SEC were stronger than those of EC.Network pharmacology analysis revealed that the chemical components of SEC with significant change exerted the effect by focusing on the mitogen-activated protein kinase(MAPK)signaling pathway.Further experiments confirmed that both of EC and SEC significantly inhibited phosphorylation of p38 mitogen-activated protein kinase(p38)induced by adenine and TGF-β and elevated expression of its upstream apoptosis signal-regulating kinase 1(ASK1),with SEC exhibiting a more pronounced inhibitory effect.Furthermore,the ASK1 inhibitor Selonsertib significantly downregulated levels of EMT and p38 phosphorylation in NRK-52E cells stimulated by TGF-β.Therefore,SEC can enhance the therapeutic effect on renal fibrosis by inhibiting the EMT process,and its specific mechanism is related to the inhibition of the ASK1/p38 signaling pathway.

鲍旖旎;朱清如;周莉;余文凯;李慧婷;张卫浩;曹岗

浙江中医药大学 药学院,浙江 杭州 310053浙江中医药大学 药学院,浙江 杭州 310053浙江中医药大学 药学院,浙江 杭州 310053浙江中医药大学 药学院,浙江 杭州 310053浙江中医药大学 药学院,浙江 杭州 310053浙江中医药大学 药学院,浙江 杭州 310053浙江中医药大学 药学院,浙江 杭州 310053

杜仲盐炙肾纤维化上皮-间充质转化p38ASK1

Eucommiae Cortexsalt-stir friedrenal fibrosisepithelial-mesenchymal transitionp38ASK1

《中国中药杂志》 2026 (7)

1891-1902,12

国家自然科学基金青年科学基金项目(82204625)国家重点研发计划项目(2024YFC3507002)浙江省自然科学基金项目(LQ23H280013)浙江省中医药科技计划项目(2023ZR009)浙江中医药大学校级科研项目(2025JKZKTS26)

10.19540/j.cnki.cjcmm.20260108.309

评论